Net Debt Summary of Asep Medical Holdings Inc

Asep Medical Holdings Inc's latest annual net debt in 2023 was -44.72 Thousand CAD , up 97.9% from previous year.
Asep Medical Holdings Inc's latest quarterly net debt in 2024 Q2 was -5301.00 CAD , down -383.76% from previous quarter.
Asep Medical Holdings Inc reported annual net debt of -2.13 Million CAD in 2022, up 59.73% from previous year.
Asep Medical Holdings Inc reported annual net debt of -5.29 Million CAD in 2021, down -4100.23% from previous year.
Asep Medical Holdings Inc reported quarterly net debt of 1336.00 CAD for 2024 Q1, up 102.99% from previous quarter.
Asep Medical Holdings Inc reported quarterly net debt of -263.11 Thousand CAD for 2023 Q3, up 69.85% from previous quarter.

Annual Net Debt Chart of Asep Medical Holdings Inc (2023 - 2019)

Name	Net Debt	Net Debt Difference
Algernon Pharmaceuticals Inc.	-125.08 Thousand CAD	64.248%
BetterLife Pharma Inc.	207.85 Thousand CAD	121.516%
BioVaxys Technology Corp.	-977.00 CAD	-4477.38%
ChitogenX Inc.	3.84 Million CAD	101.165%
Rapid Dose Therapeutics Corp.	2.29 Million CAD	101.951%
Defence Therapeutics Inc.	1.68 Million CAD	102.646%
Entheon Biomedical Corp.	-344.63 Thousand CAD	87.024%
Gemina Laboratories Ltd.	284.33 Thousand CAD	115.728%
Glow Lifetech Corp.	116.15 Thousand CAD	138.503%
Lexston Life Sciences Corp.	-390.4 Thousand CAD	88.545%
Pharmala Biotech Holdings Inc.	58.49 Thousand CAD	176.453%
Doseology Sciences Inc.	-1.06 Million CAD	95.782%
MYND Life Sciences Inc.	2.99 Million CAD	101.491%
Nova Mentis Life Science Corp.	-8088.00 CAD	-452.93%
PharmaTher Holdings Ltd.	-2.13 Million CAD	97.904%
PreveCeutical Medical Inc.	3.83 Million CAD	101.167%
Telescope Innovations Corp.	-719.49 Thousand CAD	93.784%